Skip to main content
Pidilite Industries Ltd. logo

Pidilite Industries Ltd. — Investor Relations & Filings

Ticker · PIDILITIND ISIN · INE318A01026 LEI · 335800APXGEBZ349GN74 BSE.NS Manufacturing
Open in API
Filings indexed 2,460 across all filing types
Latest filing 2022-11-22 Regulatory Filings
Country IN India
Listing BSE.NS PIDILITIND

About Pidilite Industries Ltd.

https://www.pidilite.com

Pidilite Industries Ltd. specializes in the manufacture of adhesives, sealants, and construction chemicals. The company’s extensive portfolio includes well-known brands such as Fevicol, M-Seal, Fevikwik, and Dr. Fixit. Its operations are divided into consumer and bazaar products and industrial specialties, providing solutions for waterproofing, wood finishes, tile adhesives, and maintenance. The company serves a wide range of markets, including retail consumers, professional contractors, and industrial sectors such as packaging, footwear, and automotive. Beyond adhesives, the company offers art and craft materials and hobby colors. Pidilite is characterized by its strong brand equity, a robust distribution network, and a focus on research and development to deliver innovative chemical solutions for diverse applications.

Recent filings

Filing Released Lang Actions
Intimation as per Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to stock exchanges (BSE and NSE) regarding the issue of duplicate share certificates to shareholders. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the loss of share certificates and issuance of duplicates. The content includes details of share certificates issued, shareholder names, and compliance instructions for uploading this information to the exchanges. There is no financial data, earnings information, management discussion, or report publication. The document is a regulatory compliance notification about share certificate issuance, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other specific categories like Share Issue/Capital Change (SHA) or Director's Dealing (DIRS).
2022-11-22 English
Transcript of the Earnings Call
Call Transcript Classification · 100% confidence The document is a transcript of an earnings call held on November 10, 2022, for Pidilite Industries Limited, discussing Q2 and H1 FY23 financial results. It includes detailed management commentary on financial performance, sales growth, EBITDA, raw material costs, and outlook, followed by a Q&A session with analysts. The presence of management names, detailed financial figures, and Q&A format confirms this is a full transcript of a conference call discussing quarterly earnings results. Therefore, the document fits the definition of a Call Transcript (CT). The document length is 15,000 characters, indicating it is a full transcript, not a brief announcement or summary.
2022-11-16 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 100% confidence The document is a transcript of an earnings call held on November 10, 2022, for Pidilite Industries Limited, discussing Q2 and H1 FY23 financial results. It includes detailed financial performance data, management commentary, and Q&A with analysts. The presence of a full transcript of the conference call, including management remarks and analyst questions, clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive financial discussion, consistent with a full earnings call transcript rather than a brief earnings release or announcement.
2022-11-16 English
Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is about upcoming investor meetings and does not contain any financial data, report, or results. It is an announcement of scheduled meetings rather than a report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-11-16 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of upcoming analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of material events or information. The content is about announcing the schedule of investor meetings, not a financial report, earnings release, or any other detailed financial or governance document. The document length is short (2003 characters), and it is an announcement of meetings rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-11-16 English
Audio Recording Q2FY23 Earnings Call
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges confirming that the audio recording of the Q2 FY23 Earnings Call has been uploaded on the company's website. It references the earnings call but does not contain the transcript or financial data itself. The document is only 1441 characters long and serves as an announcement of the availability of the earnings call recording. According to the rules, such a document is not the earnings release or call transcript itself but an announcement related to it. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the earnings call recording availability.
2022-11-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.